We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Annals of Pharmacy Practice and Pharmacotherapy

2021 Volume 1
Creative Commons License

The Potential Role of CD31 in Type 2 Diabetes Mellitus, an Initial Investigation


, ,
  1. Department of Chemistry, Biochemistry Division, Faculty of Science, Beni-Suef University, Beni-Suef 62511, Egypt.
  2. Department of Biochemistry, Faculty of Medicine, Minia University, Minia 61519, Egypt.
Abstract

One of the most common endocrine diseases in the general population is diabetes mellitus (DM). It is a major metabolic disease that leads to significant morbidity and mortality with micro- and macro-vascular consequences, making it one of the major public health concerns in a developing country. Chronic diabetes is not properly managed and often leads to cardiovascular problems and nephropathy. To a higher degree, research suggests that type 2 diabetes patients are a chronic inflammatory disease associated with the immune system. Therefore, the present study aimed to evaluate the CD31 marker to investigate immunological alterations. The subjects were divided into two groups: type 2 diabetes patients (diabetic group) and healthy individuals (control group). Based on our findings, CD31 of the diabetic group was significantly higher than that of the control group. In addition, the WBC and lymphocyte counts of the diabetic group were significantly higher than those of the control group. In conclusion, CD31 analysis showed a significant increase in the HbA1c of diabetic patients compared to the control group.


How to cite this article
Vancouver
Mohey M, Soliman H, Okasha A. The Potential Role of CD31 in Type 2 Diabetes Mellitus, an Initial Investigation. Ann Pharm Pract Pharmacother. 2021;1:1-8.
APA
Mohey, M., Soliman, H., & Okasha, A. (2021). The Potential Role of CD31 in Type 2 Diabetes Mellitus, an Initial Investigation. Annals of Pharmacy Practice and Pharmacotherapy, 1, 1-8.

About GalaxyPub

Find out more

Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.

Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.